Travere Therapeutics, Inc. (TVTX) has a market capitalization of $3.89B and trades at $42.13. The 52-week range is 12.91-42.13.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -75.2, Earnings Per Share (EPS) of $-0.56, annual revenue of $490.73M.
The stock has a beta of 0.88, operates in the Healthcare sector.
